Summary
This paper reviews the potential of Mesenchymal Stem Cells (MSCs) and their secretomes in decreasing inflammation markers in Polycystic Ovary Syndrome (PCOS) treatment.
Categories
Reproductive health: The paper discusses the use of Mesenchymal Stem Cells (MSCs) and their secretomes in the treatment of Polycystic Ovary Syndrome (PCOS), a common endocrine disorder in women of reproductive age.
Author(s)
GD Prayitno, K Lestari, CR Sartika, T Djuwantono
Publication Year
2022
Number of Citations
5
Related Publications
Reproductive health
- Blue light from light-emitting diodes directed at a single eye elicits a dose-dependent suppression of melatonin in horses
- Shiftwork and light at night negatively impact molecular and endocrine timekeeping in the female reproductive axis in humans and rodents
- Dysregulated mammalian estrus cycle rescued by timed activation of VIP neurons in the circadian pacemaker and late afternoon light exposure
- Visuo-perceptual task performance across the menstrual cycle in women with and without premenstrual symptoms: potential influences of estradiol and estradiol …
- Transcriptomic profiling of reward and sensory brain areas in perinatal fentanyl exposed juvenile mice